ANIK vs TXT · rev $62.2M vs P/E 19, rev $7.52B
Anika Therapeutics Inc (ANIK) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
ANIK currently screens at market cap $161.3M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the ANIK and TXT stock pages for the full models.
Not investment advice.